News | News By Subject | News by Disease News By Date | Search News

Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Wowsers! FDA Approves BioMarin (BMRN)'s Brineura, the First Drug for Batten Disease     4/28/2017
Biotech Unicorn Moderna's Vaccine Performs Well in First Human Trial     4/28/2017
Analyzing Wild Optimism and Questionable Studies for Alzheimer’s Drug Development     4/28/2017
Another Biotech is Born as Bay Area's BridgeBio Pharma Launches Eidos Therapeutics With $27 Million     4/27/2017
Genentech (RHHBY) Quietly Shelves Phase II Cancer Contender     4/27/2017
The FDA Calls Pfizer (PFE)’s Next-Generation Lung Cancer Drug a Breakthrough     4/27/2017
Some Predict Biogen (BIIB)’s Alzheimer’s Drug Will Fail     4/27/2017
AstraZeneca PLC (AZN)'s Lung Cancer Trial Gets Delayed     4/27/2017
Why High-Flying M&A Target Tesaro (TSRO) Recently Lost More Than a Quarter of Its Value     4/26/2017
Why This SoCal Pharma Could Be Your Best Bet on Alzheimer's     4/26/2017
Gilead (GILD)'s $600 Million NASH Deal Finally Bears Fruit     4/26/2017
Former Pfizer (PFE) Cancer Scientist Gets All 5 Papers Retracted     4/24/2017
Up to 4,100 Children Victims of Sanofi (SNY)'s Epilepsy Drug, Says French Regulator     4/21/2017
AbbVie (ABBV)'s PARP Inhibitor Fails to Deliver in Two Late-Stage Studies     4/20/2017
Novartis AG (NVS) Remains Hush-Hush About CAR-T Trial But the FDA is Impressed and Thinks It's a Breakthrough     4/20/2017

News from Around the Web
Obesity And 4 Other Conditions Lead Americans To The Grave, Cleveland Clinic Study     4/28/2017
Medtronic (MDT) Abbott (ABT) Could Still Find a Way Out From India's High-End Stent Market     4/28/2017
Abbott (ABT), Medtronic (MDT) Can't Pull Stents Out, Says Indian Regulator     4/27/2017
‘Mini-Me’ Brains-In-A-Dish Mimic Disease, Raise Hope For Eventual Therapies, Nature Reveals     4/27/2017
Eli Lilly (LLY) Gives No New Information On Rheumatoid Arthritis Drug Delay     4/26/2017
Acoustics Might Revolutionize Coronary Artery Disease Detection, AUM Cardio Reveals     4/26/2017
Why Too Much Sugar Is Bad For Your Brain, Boston University School of Medicine Study Reveals     4/25/2017
Why Gilead (GILD) Should Pay Close Attention And Maybe Even Fear Allergan (AGN)'s NASH Program     4/25/2017
Abbott (ABT), Medtronic (MDT) to Withdraw Stents From Indian Market     4/25/2017
Robot Radiology: Low Cost A.I. Could Screen For Cervical Cancer Better Than Humans, Lehigh University Study     4/25/2017
New Test Can ID Dangerous Bacteria With Resistance To Last-Resort Antibiotic, European Society of Clinical Microbiology and Infectious Diseases Reveals     4/24/2017
How IBM (IBM) is Using Deep Learning to Detect Diabetic Eye Disease     4/24/2017
Can Psoriatic Arthritis Lift Gilead (GILD)'s Sinking Ship?     4/20/2017
Can Scientists Rejuvenate An Aging Brain With Young Blood? Stanford University Study     4/20/2017
Entrepreneurs Are Wearing Implants Made For Diabetes In The Pursuit Of 'Human Enhancement'     4/20/2017

Press Releases
Bayer (BAY) Receives FDA Approval For Stivarga (Regorafenib) For The Second-Line Systemic Treatment Of Liver Cancer     4/28/2017
EMD Serono Release: Investigational Cladribine Tablets Data Show Greater Treatment Effect In Relapsing MS Patients At A Higher Risk Of Disease Progression     4/28/2017
eMD Release: Investigational Cladribine Tablets Data Show Greater Treatment Effect In Relapsing MS Patients At A Higher Risk Of Disease Progression     4/28/2017
Nordic Nanovector Release: Updated Results From Phase I/II Trial Of Betalutin In NHL Accepted For Presentation At The International Conference On Malignant Lymphoma In June     4/28/2017
TG Therapeutics (TGTX) Announces Preliminary Results From Ongoing Phase II Study Of TG-1101 (Ublituximab) In Patients With Multiple Sclerosis At The American Academy of Neurology     4/28/2017
enGene, Inc.'s Mucosal Gene Delivery Platform Is Successful In Targeting PD-L1 Expression In The Gut, Demonstrating Effective Treatment Of Colitis And Gvhd In Preclinical Models     4/28/2017
Flexion (FLXN) Highlights Two Clinical Data Presentations At The Osteoarthritis Research Society International 2017 World Congress     4/28/2017
Aspyrian Therapeutics Announces The Presentation Of Clinical Data Of Its Investigational Therapy Rm-1929 Demonstrating Significant Anti-Cancer Response In Recurrent Head And Neck Cancer Patients Who Have Failed All Existing Treatment Options     4/28/2017
miRagen Presents Interim Results From MRG-201 Phase I Clinical Trial Demonstrating Pharmacodynamic Activity In Human Skin Incisions     4/28/2017
FDA Approves Radius Health (RDUS)’s TYMLOS (Abaloparatide), A Bone Building Agent For The Treatment Of Postmenopausal Women With Osteoporosis At High Risk For Fracture     4/28/2017
Novartis AG (NVS) Receives FDA Approval For Rydapt® In Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML) And Three Types Of Systemic Mastocytosis (SM)     4/28/2017
Genmab A/S (GEN.CO) Announces European Marketing Authorization For DARZALEX (Daratumumab) For Relapsed Or Refractory Multiple Myeloma     4/28/2017
Sanofi (SNY) And Regeneron (REGN) Announce Kevzara (Sarilumab) Biologics License Application Resubmission Accepted For Review By The FDA     4/28/2017
Genmab A/S (GEN.CO) Announces New Phase III Combination Study Of Daratumumab In Multiple Myeloma     4/28/2017
Medeor Receives FDA Clearance Of IND Application And Special Protocol Assessment For Pivotal Clinical Study Of MDR-101     4/28/2017